Clinical Evaluation of Sleep Apnea

Clinical Evaluation of Sleep Apnea - Defining the Disruption

• Core Principle: Identify type & severity for effective management.
• Sleep Apnea Types:
  • Obstructive (OSA): Most common; upper airway collapse despite respiratory effort.
    • Key feature: Paradoxical chest/abdominal movement during events.
  • Central (CSA): Absent respiratory effort due to ↓ central ventilatory drive.
    • Often linked to heart failure (e.g., Cheyne-Stokes), stroke, or opioid use.
  • Mixed: Begins as central, then transitions to obstructive pattern during an event.
• Significance: Differentiating OSA vs. CSA is crucial as treatments vary significantly.

  ⭐ Apnea-Hypopnea Index (AHI) > 5 events/hour is diagnostic for sleep apnea when accompanied by symptoms.

Clinical Evaluation of Sleep Apnea - Symptom Sleuthing

• Key Symptoms (Patient/Partner Reported):
  • Loud, habitual snoring (often with pauses/gasps).
  • Witnessed apneas or choking episodes during sleep.
  • Excessive Daytime Sleepiness (EDS) despite adequate sleep duration.
  • Morning headaches, unrefreshing sleep, fatigue.
  • Nocturia, difficulty concentrating, irritability.
• Pertinent Risk Factors (Inquire Actively):
  • Obesity (BMI > 30 kg/m²).
  • Large neck circumference: > 17 inches (Men), > 16 inches (Women).
  • Male gender; Age > 40 years.
  • Family history of OSA; craniofacial abnormalities.
  • Alcohol/sedative use, especially before bedtime.
• Epworth Sleepiness Scale (ESS):
  • Standardized questionnaire to quantify average daytime sleepiness.
  • Score > 10 indicates significant/pathological sleepiness, warranting further investigation.

⭐ Witnessed apneas by a bed partner are a highly specific indicator for Obstructive Sleep Apnea.

Clinical Evaluation of Sleep Apnea - Examining the Airway

• General:
  • BMI: >30 kg/m² (obesity)
  • Neck circumference: >43 cm (men), >40 cm (women)
• Craniofacial Features:
  • Retrognathia, micrognathia
  • Midface hypoplasia
  • High-arched palate
  • Macroglossia
• Oropharyngeal Examination:
  • Mallampati Score: Class III or IV (↓ posterior airway space)
    • 📌 My Little Pony Tongue (Mallampati, Lingual tonsil, Palatine tonsil, Tongue base)
  • Tonsillar hypertrophy (Grades 3+, 4+)
  • Elongated/thickened uvula
  • Friedman Tongue Position (FTP) & Palate Position (FPP)
    • FTP I-IV based on tongue relative to palate & uvula.

⭐ Friedman Staging System (combining Mallampati, tonsil size, BMI) predicts OSA severity & surgical success. Stage I has highest success rate with UPPP (~80%).

Clinical Evaluation of Sleep Apnea - Sleep Study Deep Dive

• Polysomnography (PSG): Gold Standard
  • In-lab, attended (Type 1).
  • Monitors: EEG, EOG, EMG, ECG, airflow, respiratory effort, SaO2, snoring.
  • 
• Home Sleep Apnea Testing (HSAT)
  • Portable, unattended (Types 2, 3, 4).
  • Fewer channels (e.g., airflow, effort, SaO2).
  • For high pre-test probability OSA, no major comorbidities.
• Key Metrics:
  • Apnea-Hypopnea Index (AHI): $AHI = \frac{\text{Apneas + Hypopneas}}{\text{Total Sleep Time (hrs)}}$
    • Normal: < 5/hr
    • Mild: 5-14/hr
    • Moderate: 15-29/hr
    • Severe: ≥ 30/hr
  • Oxygen Desaturation Index (ODI): Desaturations (≥3-4%) per hour.
  • Respiratory Disturbance Index (RDI): AHI + RERAs (Respiratory Effort Related Arousals).

⭐ AHI is the primary metric for diagnosing Obstructive Sleep Apnea (OSA) and grading its severity.

Clinical Evaluation of Sleep Apnea - Grading Severity & Risks

• Severity (AHI/hr): Normal <5, Mild 5-15, Moderate 15-30, Severe >30.
• Risks:
  • Cardiovascular: Hypertension (HTN), MI, stroke.
  • Metabolic: Insulin resistance, Type 2 DM.
  • Neurocognitive: Somnolence, ↓concentration, mood changes.

⭐ OSA is an independent risk factor for systemic hypertension.

High‑Yield Points - ⚡ Biggest Takeaways

• Polysomnography (PSG) remains the gold standard diagnostic test for OSA.
• Apnea-Hypopnea Index (AHI) quantifies severity: Mild (5-15 events/hr), Moderate (15-30), Severe (>30).
• Epworth Sleepiness Scale (ESS) is crucial for evaluating daytime hypersomnolence.
• STOP-BANG questionnaire is a validated screening tool for high-risk patients.
• Clinical triad: loud habitual snoring, witnessed apneas, and excessive daytime sleepiness.
• Physical exam: focus on BMI, neck circumference (>40cm), tonsillar hypertrophy, retrognathia.
• Muller’s maneuver assesses upper airway collapsibility and potential obstruction site during wakefulness.